{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:03:25Z","timestamp":1788246205927,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People living with HIV (PLWH) have a higher risk for cancer compared to the general population. The prevalence of renal cell carcinoma (RCC) in PLWH has gradually increased in recent years, but relevant data on outcomes after surgery are scarce. We thus evaluated long-term outcomes after surgery in RCC patients with and without HIV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study included 67 patients with RCC, both HIV positive or negative, who underwent surgical treatment in our hospital between January 2012 and January 2021. Demographic details, clinical data, and cancer status were collected. We set the day of surgery as the baseline. The co-primary end points in this time-to-event analysis were overall survival and progression-free survival. We used a multivariate Cox model to compare the prognosis of PLWH and HIV-negative patients and present Kaplan\u2013Meier curves for the co-primary end points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 261 consecutive patients, 18 patients who forwent treatment before surgery, 133 cases with incomplete data, 16 patients classified as clinical stage IV, 11 PLWH patients did not received antiretroviral therapy and 16 patients with metastasis were excluded from the main analysis. Of the remaining 67 patients, 33 individuals had HIV and the other 34 did not. The median overall survival was 74.9\u00a0months (95% confidence interval [CI]\u2009=\u200964.6 to 85.2) in PLWH and 96.4\u00a0months (95% CI\u2009=\u200990.0 to 102.9) in the HIV-negative group. Progression-free survival was 66.4\u00a0months (95% CI\u2009=\u200953.5 to 79.3) and 90.6\u00a0months (95% CI\u2009=\u200981.1 to 100.1), respectively. RCC patients with HIV who underwent surgery had a shorter survival time (hazard ratio [HR]\u2009=\u20092.8, 95% CI\u2009=\u20091.1 to 7.0, <jats:italic>p<\/jats:italic>\u2009=\u20090.016) and an increased incidence of tumor progression (HR\u2009=\u20092.7, 95% CI\u2009=\u20091.1 to 6.8, <jats:italic>p<\/jats:italic>\u2009=\u20090.028). Univariate and multivariate Cox regression analyses showed that a lower ratio of CD4<jats:sup>+<\/jats:sup> T cells to CD8<jats:sup>+<\/jats:sup> T cells (adjusted odds ratio\u2009=\u20090.092, 95% CI\u2009=\u20090.01 to 0.70, <jats:italic>p<\/jats:italic>\u2009=\u20090.022) was associated with worse survival among PLWH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this retrospective analysis of RCC patients who underwent surgery, PLWH had worse overall survival and shorter progression-free survival compared to HIV-negative cases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07592-z","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T03:27:42Z","timestamp":1657337262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery"],"prefix":"10.1186","volume":"22","author":[{"given":"Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"issue":"5","key":"7592_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5582\/bst.2018.01269","volume":"12","author":"Q Tang","year":"2018","unstructured":"Tang Q, Lu H. HIV\/AIDS responses in China should focus on the impact of global integration. Biosci Trends. 2018;12(5):507\u20139.","journal-title":"Biosci Trends"},{"issue":"6","key":"7592_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/QAD.0b013e32835cae9c","volume":"27","author":"AJ Rodger","year":"2013","unstructured":"Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, Paredes R, Bakowska E, Engsig FN, Phillips A, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013;27(6):973\u20139.","journal-title":"AIDS"},{"issue":"6","key":"7592_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/ije\/dyp306","volume":"38","author":"M Zwahlen","year":"2009","unstructured":"Zwahlen M, Harris R, May M, Hogg R, Costagliola D, de Wolf F, Gill J, Fatkenheuer G, Lewden C, Antiretroviral Therapy Cohort C, et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol. 2009;38(6):1624\u201333.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"7592_CR4","doi-asserted-by":"publisher","first-page":"986","DOI":"10.6004\/jnccn.2018.0066","volume":"16","author":"E Reid","year":"2018","unstructured":"Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Gupta N, Johung KL, et al. Cancer in people living with HIV, version 1,2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(8):986\u20131017.","journal-title":"J Natl Compr Canc Netw"},{"key":"7592_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-med-050409-103711","volume":"62","author":"C Casper","year":"2011","unstructured":"Casper C. The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med. 2011;62:157\u201370.","journal-title":"Annu Rev Med"},{"issue":"11","key":"7592_CR6","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495\u2013504.","journal-title":"Lancet HIV"},{"issue":"9","key":"7592_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jnci\/djr076","volume":"103","author":"MS Shiels","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753\u201362.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"7592_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/cncr.31838","volume":"125","author":"KL Corrigan","year":"2019","unstructured":"Corrigan KL, Wall KC, Bartlett JA, Suneja G. Cancer disparities in people with HIV: a systematic review of screening for non-AIDS-defining malignancies. Cancer. 2019;125(6):843\u201353.","journal-title":"Cancer"},{"issue":"1","key":"7592_CR9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1186\/s12885-018-4963-8","volume":"18","author":"N Nagata","year":"2018","unstructured":"Nagata N, Nishijima T, Niikura R, Yokoyama T, Matsushita Y, Watanabe K, Teruya K, Kikuchi Y, Akiyama J, Yanase M, et al. Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study. BMC Cancer. 2018;18(1):1066.","journal-title":"BMC Cancer"},{"issue":"5","key":"7592_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","volume":"52","author":"MS Shiels","year":"2009","unstructured":"Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52(5):611\u201322.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"7592_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jjco\/hyw034","volume":"46","author":"C Pang","year":"2016","unstructured":"Pang C, Guan Y, Li H, Chen W, Zhu G. Urologic cancer in China. Jpn J Clin Oncol. 2016;46(6):497\u2013501.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"7592_CR12","doi-asserted-by":"publisher","first-page":"78.e71","DOI":"10.1016\/j.urolonc.2020.08.029","volume":"39","author":"K Tamura","year":"2021","unstructured":"Tamura K, Ando R, Takahara K, Ito T, Kanao K, Yasui T, Shiroki R, Miyake H. Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy. Urol Oncol. 2021;39(1):78.e71-78.e78.","journal-title":"Urol Oncol"},{"key":"7592_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.07.013","author":"K Tamura","year":"2020","unstructured":"Tamura K, Matsushita Y, Watanabe H, Motoyama D, Ito T, Sugiyama T, Otsuka A, Miyake H. Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy. Urol Oncol. 2020. https:\/\/doi.org\/10.1016\/j.urolonc.2019.07.013.","journal-title":"Urol Oncol"},{"issue":"4","key":"7592_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.eururo.2011.06.041","volume":"60","author":"M Sun","year":"2011","unstructured":"Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S, Pantuck AJ, Zigeuner R, Karakiewicz PI. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 2011;60(4):644\u201361.","journal-title":"Eur Urol"},{"issue":"1","key":"7592_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12885-019-5375-0","volume":"19","author":"YZY Xu","year":"2019","unstructured":"Xu YZY, Wang X, Kang J, Liu X. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis. BMC Cancer. 2019;19(1):168.","journal-title":"BMC Cancer"},{"issue":"1","key":"7592_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.euo.2019.10.002","volume":"3","author":"RG DiNatale","year":"2020","unstructured":"DiNatale RG, Xie W, Becerra MF, Silagy AW, Attalla K, Sanchez A, Mano R, Marcon J, Blum KA, Benfante NE, et al. The association between small primary tumor size and prognosis in metastatic renal cell carcinoma: insights from two independent cohorts of patients who underwent cytoreductive nephrectomy. Eur Urol Oncol. 2020;3(1):47\u201356.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"7592_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12981-018-0200-4","volume":"15","author":"WM Han","year":"2018","unstructured":"Han WM, Apornpong T, Kerr SJ, Hiransuthikul A, Gatechompol S, Do T, Ruxrungtham K, Avihingsanon A. CD4\/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV. AIDS Res Ther. 2018;15(1):13.","journal-title":"AIDS Res Ther"},{"issue":"Suppl 1","key":"7592_CR18","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.21037\/atm.2019.01.50","volume":"7","author":"U Swami","year":"2019","unstructured":"Swami U, Nussenzveig RH, Haaland B, Agarwal N. Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement. Ann Transl Med. 2019;7(Suppl 1):S18.","journal-title":"Ann Transl Med"},{"key":"7592_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3389\/fonc.2020.01541","volume":"10","author":"TGY Tong","year":"2020","unstructured":"Tong TGY, Xiong H, Wang L, Pang J. A meta-analysis of Glasgow prognostic score and modified Glasgow prognostic score as biomarkers for predicting survival outcome in renal cell carcinoma. Front Oncol. 2020;10:1541.","journal-title":"Front Oncol"},{"issue":"5","key":"7592_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/1078155219890032","volume":"26","author":"NCA\u00d6 Demircan","year":"2020","unstructured":"Demircan NCA\u00d6, Ba\u015fo\u011fluT\u00fcyl\u00fc T, et al. Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib. J Oncol Pharm Pract. 2020;26(5):1147\u201355.","journal-title":"J Oncol Pharm Pract"},{"issue":"25","key":"7592_CR21","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1200\/JCO.20.00721","volume":"38","author":"JM Scott","year":"2020","unstructured":"Scott JM, Edvardsen E, Jones LW. Performance status in cancer: not broken, but time for an upgrade? J Clin Oncol. 2020;38(25):2824\u20139.","journal-title":"J Clin Oncol"},{"issue":"7","key":"7592_CR22","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/cncr.11234","volume":"97","author":"BC Leibovich","year":"2003","unstructured":"Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97(7):1663\u201371.","journal-title":"Cancer"},{"issue":"8","key":"7592_CR23","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1111\/1759-7714.13519","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Chen Y, Wang Y, Liu J, Wen Z, Chen H, Zhu Y, Wang J, Wan L, Li F, et al. Lung cancer surgery in HIV-infected patients: an analysis of postoperative complications and long-term survival. Thorac Cancer. 2020;11(8):2146\u201354.","journal-title":"Thorac Cancer"},{"key":"7592_CR24","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DYCXW Heng","year":"2009","unstructured":"Heng DYCXW, Regan MM, et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009;27:5794\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"7592_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/ajco.12487","volume":"12","author":"WL Ong","year":"2016","unstructured":"Ong WL, King K, Koh TL, Chipman M, Royce P, Hoy J, Millar JL. HIV and renal cell carcinoma: experience in an Australian statewide HIV center. Asia Pac J Clin Oncol. 2016;12(2):188\u201393.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"8","key":"7592_CR26","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/QAD.0000000000002200","volume":"33","author":"KMSK Sigel","year":"2019","unstructured":"Sigel KMSK, Wisnivesky JP, Park LS, Kong CY, Silverberg MJ, et al. Short-term outcomes for lung cancer resection surgery in HIV infection. AIDS. 2019;33(8):1353\u201360.","journal-title":"AIDS"},{"issue":"5","key":"7592_CR27","doi-asserted-by":"publisher","first-page":"E1558","DOI":"10.1002\/lary.29206","volume":"131","author":"GJNM McGinnis","year":"2021","unstructured":"McGinnis GJNM, Bvochora-Nsingo M, Chiyapo S, Balang D, Ralefala T, et al. Management of head and neck cancers with or without comorbid HIV infection in Botswana. Laryngoscope. 2021;131(5):E1558-e1566.","journal-title":"Laryngoscope"},{"issue":"3","key":"7592_CR28","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","volume":"2","author":"CLP Mussini","year":"2015","unstructured":"Mussini CLP, Cozzi-Lepri A, et al. CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. Lancet HIV. 2015;2(3):e98\u2013106.","journal-title":"Lancet HIV"},{"issue":"1","key":"7592_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2012.09.013","volume":"66","author":"S Serrano-Villar","year":"2013","unstructured":"Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad Fernandez M, Madrid N, Dronda F, Zamora J, Munoz-Fernandez MA, et al. The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect. 2013;66(1):57\u201366.","journal-title":"J Infect"},{"issue":"4","key":"7592_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"EWCRW Jonasch","year":"2021","unstructured":"Jonasch EWCRW. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17(4):245\u201361.","journal-title":"Nat Rev Nephrol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07592-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07592-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T03:27:46Z","timestamp":1657337266000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07592-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7592"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07592-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,9]]},"assertion":[{"value":"17 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors were granted approval from the human ethics committee of Beijing Youan Hospital. Each participating hospital reviewed and approved the study prior to patient enrollment. All participants provided written informed consent. All methods were carried out in accordance with relevant guidelines (human ethics guidelines of Beijing Youan Hospital).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"605"}}